Monday, October 21, 2019 1:22:33 PM
But if you want something mildly positive here it is:
1) The relationship with the primary developer is shaky, but still intact (having to replace the primary developer would likely not be feasible).
2) The problem is not software or hardware design perse, but the interface between instruments and camera system with the robot.
3) The secondary supplier who makes "devices" (instruments?) according the prospectus seems replaceable if needed.
4) It seems this secondary supplier is has messed things up big time for us, although it does not absolve Titan management either. They should have been on top of it, and made changes earlier even if meant a delay. It's a serious miscalculation, probably in part due to doing too much at once, but market perception could shift...
5) Titan likely playing legal hardball with that supplier as they should, but it means total silence for us...
6)PPS might recover if current funding round is successful.
As to the fact there may not be any funding, and the fact there are more to come, yeah, I got nothing...except fire sale and get a few bucks per share.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM